CoChat

Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men

Open access
Ismail, Shaiful Bahari, Wan Mohammad, Wan Mohd Zahiruddin, George, Annie, Nik Hussain, Nik Hazlina, Musthapa Kamal, Zatul Mufiza, Liske, Eckehard · 2012 · Evidence-based Complementary and Alternative Medicine

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

Abstract

Eurycoma longifolia is reputed as an aphrodisiac and remedy for decreased male libido. A randomized, double-blind, placebo controlled, parallel group study was carried out to investigate the clinical evidence of E. longifolia in men. The 12-week study in 109 men between 30 and 55 years of age consisted of either treatment of 300 mg of water extract of E. longifolia (Physta) or placebo. Primary endpoints were the Quality of Life investigated by SF-36 questionnaire and Sexual Well-Being investigated by International Index of Erectile Function (IIEF) and Sexual Health Questionnaires (SHQ); Seminal Fluid Analysis (SFA), fat mass and safety profiles. Repeated measures ANOVA analysis was used to compare changes in the endpoints. The E. longifolia (EL) group significantly improved in the domain Physical Functioning of SF-36, from baseline to week 12 compared to placebo (P = 0.006) and in between group at week 12 (P = 0.028). The EL group showed higher scores in the overall Erectile Function domain in IIEF (P < 0.001), sexual libido (14% by week 12), SFA- with sperm motility at 44.4%, and semen volume at 18.2% at the end of treatment. Subjects with BMI ≥ 25 kg/m(2) significantly improved in fat mass lost (P = 0.008). All safety parameters were comparable to placebo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2012/429268

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Number of subjects as in the Intention-to-Treat analysis datasets by primary* and secondary** outcomes. Subjects were omitted for analysis if they have no baseline data and/or without at least one postbaseline evaluation at week-6 or week-12. For SFA, only 36 subjects who turned up at both visit 2 and visit 4 were included for efficacy analysis. For safety profiles, the full dataset included all subjects who took at least one dose of study medication and had at least one postbaseline efficacy evaluation.
Figure 1 Number of subjects as in the Intention-to-Treat analysis datasets by primary* and secondary** outcomes. Subjects were omitted for analysis if they have no baseline data and/or without at least one postbaseline evaluation at week-6 or week-12. For SFA, only 36 subjects who turned up at both visit 2 and visit 4 were included for efficacy analysis. For safety profiles, the full dataset included all subjects who took at least one dose of study medication and had at least one postbaseline efficacy evaluation.CC BY · PubMed Central
Figure 2 Mean values of overall scores (±SEM) of Physical Functioning domain from baseline to week 12 for E. longifolia (The dark grey column, n = 52) and placebo (the grey column, n = 50).
Figure 2 Mean values of overall scores (±SEM) of Physical Functioning domain from baseline to week 12 for E. longifolia (The dark grey column, n = 52) and placebo (the grey column, n = 50).CC BY · PubMed Central
Figure 3 Mean seminal fluid volumes (mL; ±SEM) for subjects with low baseline (Day 0) values with cutoff 3.5 mL after 12 weeks intake of E. longifolia (The dark grey column, n = 13) and placebo (the grey column, n = 9).
Figure 3 Mean seminal fluid volumes (mL; ±SEM) for subjects with low baseline (Day 0) values with cutoff 3.5 mL after 12 weeks intake of E. longifolia (The dark grey column, n = 13) and placebo (the grey column, n = 9).CC BY · PubMed Central
Figure 4 Mean motility (%) (±SEM) for all subjects (total, n = 22) and subgroup of subjects (n = 11) with low starting values at baseline (Day 0) and after 12-week treatment with E. longifolia.
Figure 4 Mean motility (%) (±SEM) for all subjects (total, n = 22) and subgroup of subjects (n = 11) with low starting values at baseline (Day 0) and after 12-week treatment with E. longifolia.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 2

  1. Hamzah S Yusof A The ergogenic effects of Eurycoma longifolia Jack: a pilot study British Journal of Sports Medinice 2003 37 465 466
  2. Tambi MI Nutrients and botanicals for optimizing men's health. Examining the evidence for Eurycoma longifolia Jack, the Malaysian Ginseng in men's health Asian Journal of Andrology 2009 11 supplement 5 37 38

Cited by

Metadata

Authors
Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E.
Affiliations
  • Universiti Sains Malaysia (MY)
  • School of Medical Sciences, Universiti Sains Malaysia, Kelantan, 16150 Kubang Kerian, Malaysia
  • Biotropics Malaysia (Malaysia) (MY)
  • Department of Science and Clinical Trial, Biotropics Malaysia Berhad, Level 52, Menara TM, Jalan Pantai Baharu, 50672 Kuala Lumpur, Malaysia
  • Technische Universität Braunschweig (DE)
Corresponding author
Ismail, Shaiful Bahari
Venue
Evidence-based Complementary and Alternative Medicine
Published
2012
Volume
2012
Pages
1-10
ISSN
  • 1741-427X (ISSN-L)
  • 1741-4288
OpenAlex
W2166312097
Cited by
61
References
25
Citations by year
2025: 4 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 6
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Evidence-based Complementary and Alternative Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
Keywords
Eurycoma longifolia, aphrodisiacs, male sexual dysfunction, erectile function, sexual well-being, quality of life, male libido, sperm motility, seminal fluid analysis, fat loss, body mass index, herbal medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.